Peddock Capital Advisors LLC acquired a new position in SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 3,057 shares of the exchange traded fund’s stock, valued at approximately $302,000.
Other institutional investors have also bought and sold shares of the company. Scarborough Advisors LLC bought a new stake in SPDR S&P Biotech ETF in the fourth quarter worth about $32,000. ORG Partners LLC bought a new stake in SPDR S&P Biotech ETF in the second quarter worth about $40,000. Vima LLC purchased a new stake in SPDR S&P Biotech ETF during the fourth quarter valued at about $45,000. Resources Management Corp CT ADV lifted its stake in SPDR S&P Biotech ETF by 30.3% during the second quarter. Resources Management Corp CT ADV now owns 593 shares of the exchange traded fund’s stock valued at $55,000 after buying an additional 138 shares in the last quarter. Finally, SOA Wealth Advisors LLC. lifted its stake in SPDR S&P Biotech ETF by 79.8% during the first quarter. SOA Wealth Advisors LLC. now owns 597 shares of the exchange traded fund’s stock valued at $57,000 after buying an additional 265 shares in the last quarter.
SPDR S&P Biotech ETF Trading Down 0.6 %
XBI stock traded down $0.55 during mid-day trading on Wednesday, reaching $96.55. 1,768,535 shares of the stock traded hands, compared to its average volume of 9,566,846. SPDR S&P Biotech ETF has a 52-week low of $63.80 and a 52-week high of $103.52. The company has a market cap of $7.36 billion, a P/E ratio of 11.47 and a beta of 1.11. The stock’s fifty day moving average is $98.60 and its 200-day moving average is $94.09.
SPDR S&P Biotech ETF Company Profile
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.
Read More
- Five stocks we like better than SPDR S&P Biotech ETF
- What Are Dividend Contenders? Investing in Dividend Contenders
- 3 Momentum Trades for October With Ample Upside Ahead
- Most Volatile Stocks, What Investors Need to Know
- Roblox Dips on Short Report—Here’s Why It Could Bounce Back Fast
- Technology Stocks Explained: Here’s What to Know About Tech
- 2 Reasons to Jump on Apple Stock Now and 1 Reason to Think Twice
Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report).
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.